Requires every individual or group health insurance contract effective on or after January 1, 2026, to provide coverage to the insured and the insured's spouse and dependents for all FDA-approved contraceptive drugs, devices and other products.
Mandates all health insurance contracts from January 1, 2026, to cover FDA-approved contraceptives, sterilization, contraception counseling, follow-up services, and a twelve-month supply for Medicaid recipients.
Mandates health insurance coverage for FDA approved contraceptive drug, device or therapeutic equivalent.
Mandates health insurance coverage for FDA approved contraceptive drug, device or therapeutic equivalent.
Requires every individual or group health insurance plan on or after January 1, 2026, that provides benefits to reimburse child service providers for therapy services offered through EOHHS certified Kids Connect/Therapeutic Services.
Requires every individual or group health insurance plan on or after January 1, 2026, that provides benefits to reimburse child service providers for therapy services offered through EOHHS certified Kids Connect/Therapeutic Services.
Requires every individual or group health insurance contract, plan, or policy to provide coverage for at least one type of buprenorphine for each form of administration.
Removes the age restriction for benefits coverage and requires, for health insurance policies issued or renewed on or after January 1, 2026, that coverage must include reimbursement for applied behavior analysis provider services.
Adds new sections that set forth conditions for pharmacists to prescribe tobacco cessation drug therapies, including education approved by state board of pharmacy. The cessation therapies to be covered by all health insurance carriers on or after 1/1/26.
Adds new sections that set forth conditions for pharmacists to prescribe tobacco cessation drug therapies, including education approved by state board of pharmacy. The cessation therapies to be covered by all health insurance carriers on or after 1/1/26.